相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
Arman A. Shahriar et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2022)
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
Benjamin N. Rome et al.
JAMA NETWORK OPEN (2021)
Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
Jonathan D. Alpern et al.
JAMA NETWORK OPEN (2020)
New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs
Radha Rajasingham et al.
CLINICAL INFECTIOUS DISEASES (2019)
Specialty Drug Price Trends in the Federal 340B Drug Discount Program
Cho-Han Lee et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2019)
Broken drug markets in infectious diseases: Opportunities outside the private sector?
Jonathan D. Alpern et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs
Inmaculada Hernandez et al.
HEALTH AFFAIRS (2019)
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
Angela Loyse et al.
LANCET INFECTIOUS DISEASES (2019)
Association Between Market Competition and Prices of Generic Topical Dermatology Drugs
David G. Li et al.
JAMA DERMATOLOGY (2018)
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?
Rena M. Conti et al.
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2018)
Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States
Jonathan D. Alpern et al.
CLINICAL INFECTIOUS DISEASES (2017)
High Generic Drug Prices and Market Competition A Retrospective Cohort Study
Chintan V. Dave et al.
ANNALS OF INTERNAL MEDICINE (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N. Galgiani et al.
CLINICAL INFECTIOUS DISEASES (2016)
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis
Matthew Merry et al.
CLINICAL INFECTIOUS DISEASES (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Essential Medicines in the United States - Why Access Is Diminishing
Jonathan D. Alpern et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Trends in the Utilization of, Spending on, and Prices for Outpatient Antifungal Agents in US Medicaid Programs: 1991-2009
Vibha C. A. Desai et al.
CLINICAL THERAPEUTICS (2012)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America
Stanley W. Chapman et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical practice guidelines for the management of sporotrichosis: 2007 update by the infectious diseases society of America
Carol A. Kauffman et al.
CLINICAL INFECTIOUS DISEASES (2007)
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the infectious diseases society of America
L. Joseph Wheat et al.
CLINICAL INFECTIOUS DISEASES (2007)
Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection
CJ Fichtenbaum et al.
AIDS (2000)
分享论文
